Raras
Buscar doenças, sintomas, genes...
Não-compactação ventricular esquerda
ORPHA:54260CID-10 · I42.8CID-11 · BC44DOENÇA RARA

A não compactação do ventrículo esquerdo (NCVE) é uma cardiomiopatia rara caracterizada anatomicamente por trabéculas ventriculares esquerdas proeminentes e recessos intratrabeculares profundos, causando disfunção sistólica e diastólica progressiva, anormalidades de condução e, ocasionalmente, eventos tromboembólicos.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A não compactação do ventrículo esquerdo (NCVE) é uma cardiomiopatia rara caracterizada anatomicamente por trabéculas ventriculares esquerdas proeminentes e recessos intratrabeculares profundos, causando disfunção sistólica e diastólica progressiva, anormalidades de condução e, ocasionalmente, eventos tromboembólicos.

Pesquisas ativas
3 ensaios
7 total registrados no ClinicalTrials.gov
Publicações científicas
1.034 artigos
Último publicado: 2026 May
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: I42.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

❤️
Coração
30 sintomas
🫁
Pulmão
2 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

Palpitações
Arritmia
Disfunção diastólica do ventrículo esquerdo
Disfunção sistólica do ventrículo esquerdo
Coração esquerdo hipoplásico
Bloqueio atrioventricular de primeiro grau
42sintomas
Sem dados (42)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 42 características clínicas mais associadas, ordenadas por frequência.

PalpitaçõesPalpitations
ArritmiaArrhythmia
Disfunção diastólica do ventrículo esquerdoLeft ventricular diastolic dysfunction
Disfunção sistólica do ventrículo esquerdoLeft ventricular systolic dysfunction
Coração esquerdo hipoplásicoHypoplastic left heart

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.034PubMed
Últimos 10 anos200publicações
Pico202366 papers
Linha do tempo
2026Hoje · 2026🧪 2004Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

15 genes identificados com associação a esta condição.

Autosomal dominantAutosomal recessiveMitochondrial inheritanceX-linked recessive
ACTC1Actin, alpha cardiac muscle 1Major susceptibility factor inAltamente restrito
FUNÇÃO

Actins are highly conserved proteins that are involved in various types of cell motility and are ubiquitously expressed in all eukaryotic cells

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (5)
Regulation of CDH1 FunctionFormation of the dystrophin-glycoprotein complex (DGC)Striated Muscle ContractionRHOB GTPase cycleRHOA GTPase cycle
MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1R

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death.

OUTRAS DOENÇAS (7)
atrial septal defect 5dilated cardiomyopathy 1Rhypertrophic cardiomyopathy 11hypertrophic cardiomyopathy
HGNC:143UniProt:P68032
MIB1E3 ubiquitin-protein ligase MIB1Disease-causing germline mutation(s) (loss of function) inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors. Probably mediates ubiquitination and subsequent proteasomal degradation of DAPK1, thereby antagonizing anti-apoptotic effects of DAPK1 to promote TNF-induced apoptosis (By similarity). Involved in ubiquitination of centriolar satel

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centriolar satelliteCell membrane

VIAS BIOLÓGICAS (6)
Activated NOTCH1 Transmits Signal to the NucleusNOTCH3 Activation and Transmission of Signal to the NucleusNOTCH2 Activation and Transmission of Signal to the NucleusConstitutive Signaling by NOTCH1 PEST Domain MutantsConstitutive Signaling by NOTCH1 HD+PEST Domain Mutants
MECANISMO DE DOENÇA

Left ventricular non-compaction 7

A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC7 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
26.4 TPM
Cervix Ectocervix
26.4 TPM
Aorta
25.6 TPM
Útero
25.5 TPM
Cervix Endocervix
24.0 TPM
OUTRAS DOENÇAS (2)
left ventricular noncompaction 7left ventricular noncompaction
HGNC:21086UniProt:Q86YT6
TBX20T-box transcription factor TBX20Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a transcriptional activator and repressor required for cardiac development and may have key roles in the maintenance of functional and structural phenotypes in adult heart

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (1)
Cardiogenesis
MECANISMO DE DOENÇA

Atrial septal defect 4

A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. Patients show other heart abnormalities including defects in septation, chamber growth and valvulogenesis. The disease is not associated with defects in the cardiac conduction system or with non-cardiac abnormalities.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Átrio
20.7 TPM
Bladder
9.8 TPM
Coração - Ventrículo esquerdo
5.4 TPM
Artéria coronária
4.0 TPM
Pituitária
0.9 TPM
OUTRAS DOENÇAS (3)
atrial septal defect 4atrial septal defect, ostium secundum typeleft ventricular noncompaction
HGNC:11598UniProt:Q9UMR3
MIB2E3 ubiquitin-protein ligase MIB2Major susceptibility factor inTolerante
FUNÇÃO

E3 ubiquitin-protein ligase that mediates ubiquitination of Delta receptors, which act as ligands of Notch proteins. Positively regulates the Delta-mediated Notch signaling by ubiquitinating the intracellular domain of Delta, leading to endocytosis of Delta receptors

LOCALIZAÇÃO

CytoplasmEndosome

VIAS BIOLÓGICAS (9)
Activated NOTCH1 Transmits Signal to the NucleusNOTCH3 Activation and Transmission of Signal to the NucleusNOTCH2 Activation and Transmission of Signal to the NucleusConstitutive Signaling by NOTCH1 PEST Domain MutantsConstitutive Signaling by NOTCH1 HD+PEST Domain Mutants
EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
83.8 TPM
Cerebelo
75.1 TPM
Ovário
74.7 TPM
Cérebro - Hemisfério cerebelar
68.5 TPM
Cervix Endocervix
61.3 TPM
OUTRAS DOENÇAS (1)
left ventricular noncompaction
HGNC:30577UniProt:Q96AX9
LMNAPrelamin-A/CMajor susceptibility factor inAltamente restrito
FUNÇÃO

Lamins are intermediate filament proteins that assemble into a filamentous meshwork, and which constitute the major components of the nuclear lamina, a fibrous layer on the nucleoplasmic side of the inner nuclear membrane (PubMed:10080180, PubMed:10580070, PubMed:10587585, PubMed:10814726, PubMed:11799477, PubMed:12075506, PubMed:12927431, PubMed:15317753, PubMed:18551513, PubMed:18611980, PubMed:2188730, PubMed:22431096, PubMed:2344612, PubMed:23666920, PubMed:24741066, PubMed:31434876, PubMed:

LOCALIZAÇÃO

Nucleus laminaNucleus envelopeNucleus, nucleoplasmNucleus matrixNucleus speckle

VIAS BIOLÓGICAS (1)
Initiation of Nuclear Envelope (NE) Reformation
MECANISMO DE DOENÇA

Emery-Dreifuss muscular dystrophy 2, autosomal dominant

A form of Emery-Dreifuss muscular dystrophy, a degenerative myopathy characterized by weakness and atrophy of muscle without involvement of the nervous system, early contractures of the elbows, Achilles tendons and spine, and cardiomyopathy associated with cardiac conduction defects.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
392.7 TPM
Aorta
300.6 TPM
Skin Not Sun Exposed Suprapubic
297.7 TPM
Skin Sun Exposed Lower leg
272.6 TPM
Útero
255.8 TPM
OUTRAS DOENÇAS (23)
restrictive dermopathy 2familial partial lipodystrophy, Dunnigan typedilated cardiomyopathy-hypergonadotropic hypogonadism syndromemandibuloacral dysplasia with type A lipodystrophy
HGNC:6636UniProt:P02545
TPM1Tropomyosin alpha-1 chainDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds to actin filaments in muscle and non-muscle cells (PubMed:23170982). Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction (PubMed:23170982). Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments

LOCALIZAÇÃO

Cytoplasm, cytoskeleton

VIAS BIOLÓGICAS (2)
Smooth Muscle ContractionStriated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 3

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
1299.6 TPM
Esôfago - Muscular
1291.9 TPM
Cólon sigmoide
992.0 TPM
Esôfago - Junção
988.7 TPM
Coração - Átrio
959.4 TPM
OUTRAS DOENÇAS (4)
dilated cardiomyopathy 1Yhypertrophic cardiomyopathy 3familial isolated dilated cardiomyopathyleft ventricular noncompaction
HGNC:12010UniProt:P09493
MYH7BMyosin-7BDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in muscle contraction

LOCALIZAÇÃO

Membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
78.5 TPM
Coração - Átrio
49.4 TPM
Testículo
32.8 TPM
Músculo esquelético
9.5 TPM
Brain Spinal cord cervical c-1
8.8 TPM
OUTRAS DOENÇAS (1)
left ventricular noncompaction
HGNC:15906UniProt:A7E2Y1
MYH7Myosin-7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle

LOCALIZAÇÃO

Cytoplasm, myofibrilCytoplasm, myofibril, sarcomere

MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 1

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
4513.7 TPM
Músculo esquelético
3692.8 TPM
Coração - Átrio
592.2 TPM
Pâncreas
5.3 TPM
Hipotálamo
4.9 TPM
OUTRAS DOENÇAS (12)
MYH7-related skeletal myopathymyopathy, myosin storage, autosomal recessivedilated cardiomyopathy 1Scongenital myopathy 7A, myosin storage, autosomal dominant
HGNC:7577UniProt:P12883
TNNT2Troponin T, cardiac muscleDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Troponin T is the tropomyosin-binding subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 2

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
2785.9 TPM
Coração - Átrio
2374.2 TPM
Nervo tibial
27.9 TPM
Brain Frontal Cortex BA9
20.2 TPM
Rim - Córtex
18.5 TPM
OUTRAS DOENÇAS (7)
cardiomyopathy, familial restrictive, 3dilated cardiomyopathy 1Dhypertrophic cardiomyopathy 2hypertrophic cardiomyopathy
HGNC:11949UniProt:P45379
DTNADystrobrevin alphaCandidate gene tested inRestrito
FUNÇÃO

May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors

LOCALIZAÇÃO

CytoplasmSynapseCell membrane

VIAS BIOLÓGICAS (1)
Formation of the dystrophin-glycoprotein complex (DGC)
MECANISMO DE DOENÇA

Left ventricular non-compaction 1

A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC1 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
84.4 TPM
Hipotálamo
62.3 TPM
Substância negra
60.3 TPM
Cérebro - Amígdala
57.5 TPM
Cerebelo
57.5 TPM
OUTRAS DOENÇAS (3)
myopathy with myalgia, increased serum creatine kinase, and with or without episodic rhabdomyolysis 2left ventricular noncompaction 1left ventricular noncompaction
HGNC:3057UniProt:Q9Y4J8
PLEKHM2Pleckstrin homology domain-containing family M member 2Major susceptibility factor inTolerante
FUNÇÃO

Plays a role in lysosomes movement and localization at the cell periphery acting as an effector of ARL8B. Required for ARL8B to exert its effects on lysosome location, recruits kinesin-1 to lysosomes and hence direct their movement toward microtubule plus ends. Binding to ARL8B provides a link from lysosomal membranes to plus-end-directed motility (PubMed:22172677, PubMed:24088571, PubMed:25898167, PubMed:28325809). Critical factor involved in NK cell-mediated cytotoxicity. Drives the polarizati

LOCALIZAÇÃO

CytoplasmLysosome membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Córtex cerebral
193.7 TPM
Brain Frontal Cortex BA9
185.9 TPM
Brain Anterior cingulate cortex BA24
127.9 TPM
Cerebelo
125.7 TPM
Cérebro - Hemisfério cerebelar
115.5 TPM
OUTRAS DOENÇAS (1)
left ventricular noncompaction
HGNC:29131UniProt:Q8IWE5
LDB3LIM domain-binding protein 3Major susceptibility factor inTolerante
FUNÇÃO

May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton

LOCALIZAÇÃO

Cytoplasm, perinuclear regionCell projection, pseudopodiumCytoplasm, cytoskeletonCytoplasm, myofibril, sarcomere, Z line

MECANISMO DE DOENÇA

Cardiomyopathy, dilated, 1C, with or without left ventricular non-compaction

A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. Cardiomyopathy dilated type 1C is associated with left ventricular non-compaction in some patients. Left ventricular non-compaction is characterized by numerous prominent trabeculations and deep intertrabecular recesses in hypertrophied and hypokinetic segments of the left ventricle.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
372.3 TPM
Músculo esquelético
338.8 TPM
Coração - Átrio
299.7 TPM
Artéria tibial
89.9 TPM
Aorta
57.8 TPM
OUTRAS DOENÇAS (7)
myofibrillar myopathy 4dilated cardiomyopathy 1Cfamilial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, biventricular form
HGNC:15710UniProt:O75112
PKP2Plakophilin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25208567). Regulates focal adhesion turnover resulting in changes in focal adhesion size, cell adhesion and cell spreading, potentially via transcriptional modulation of beta-integrins (PubMed:23884246). Required to maintain gingival epithelial barrier function (PubMed:34368962). Important component of the desmosome that is also required for localization of desmosome component pro

LOCALIZAÇÃO

NucleusCell junction, desmosomeCell junctionCytoplasm

VIAS BIOLÓGICAS (1)
Formation of the cornified envelope
MECANISMO DE DOENÇA

Arrhythmogenic right ventricular dysplasia, familial, 9

A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
66.9 TPM
Coração - Átrio
41.6 TPM
Glândula salivar
35.8 TPM
Ovário
20.1 TPM
Cólon transverso
19.3 TPM
OUTRAS DOENÇAS (6)
arrhythmogenic right ventricular dysplasia 9Brugada syndromefamilial isolated arrhythmogenic ventricular dysplasia, left dominant formfamilial isolated arrhythmogenic ventricular dysplasia, right dominant form
HGNC:9024UniProt:Q99959
MYBPC3Myosin-binding protein C, cardiac-typeCandidate gene tested inTolerante
FUNÇÃO

Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
Striated Muscle Contraction
MECANISMO DE DOENÇA

Cardiomyopathy, familial hypertrophic, 4

A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death.

EXPRESSÃO TECIDUAL(Tecido-específico)
Coração - Ventrículo esquerdo
1351.0 TPM
Coração - Átrio
991.7 TPM
Sangue
7.7 TPM
Baço
4.9 TPM
Testículo
4.1 TPM
OUTRAS DOENÇAS (5)
left ventricular noncompaction 10hypertrophic cardiomyopathy 4hypertrophic cardiomyopathyfamilial isolated dilated cardiomyopathy
HGNC:7551UniProt:Q14896
PRDM16Histone-lysine N-methyltransferase PRDM16Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription regulator that acts both as a histone methyltransferase or chromatin adapter, depending on the context (PubMed:12816872). In the cytoplasm, acts as a histone methyltransferase, which catalyzes monomethylation of 'Lys-9' of free histone H3 (H3K9me1) during translation (By similarity). Monomethylated histone H3 is then transported to the nucleus and incorporated into nucleosomes where SUV39H methyltransferases (SUV39H1 and SUV39H2) use it as a substrate to catalyze histone H3 'Lys-9'

LOCALIZAÇÃO

NucleusChromosomeCytoplasm

VIAS BIOLÓGICAS (1)
PKMTs methylate histone lysines
MECANISMO DE DOENÇA

Left ventricular non-compaction 8

A form of left ventricular non-compaction, a cardiomyopathy due to myocardial morphogenesis arrest and characterized by a hypertrophic left ventricle, a severely thickened 2-layered myocardium, numerous prominent trabeculations, deep intertrabecular recesses, and poor systolic function. Clinical manifestations are variable. Some affected individuals experience no symptoms at all, others develop heart failure. In some cases, left ventricular non-compaction is associated with other congenital heart anomalies. LVNC8 is an autosomal dominant condition.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
37.2 TPM
Artéria tibial
30.3 TPM
Artéria coronária
24.6 TPM
Nervo tibial
20.5 TPM
Tireoide
18.6 TPM
OUTRAS DOENÇAS (4)
left ventricular noncompaction 8chromosome 1p36 deletion syndromefamilial isolated dilated cardiomyopathyleft ventricular noncompaction
HGNC:14000UniProt:Q9HAZ2

Variantes genéticas (ClinVar)

443 variantes patogênicas registradas no ClinVar.

🧬 ACTC1: NM_005159.5(ACTC1):c.716A>T (p.Glu239Val) ()
🧬 ACTC1: GRCh37/hg19 15q14(chr15:34120023-39406778)x1 ()
🧬 ACTC1: NM_005159.5(ACTC1):c.558C>G (p.Asp186Glu) ()
🧬 ACTC1: NM_005159.5(ACTC1):c.890C>G (p.Ala297Gly) ()
🧬 ACTC1: NM_005159.5(ACTC1):c.179C>T (p.Ala60Val) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 2,454 variantes classificadas pelo ClinVar.

1595
859
VUS (65.0%)
Benigna (35.0%)
VARIANTES MAIS SIGNIFICATIVAS
DTNA: NM_001386795.1(DTNA):c.1343del (p.Ser448fs) [Uncertain significance]
PRDM16: NM_022114.4(PRDM16):c.1251_1264del (p.Cys419fs) [Uncertain significance]
PRDM16: NM_022114.4(PRDM16):c.3349G>A (p.Asp1117Asn) [Uncertain significance]
PRDM16: NM_022114.4(PRDM16):c.1631A>G (p.Asp544Gly) [Uncertain significance]
DTNA: NM_001386795.1(DTNA):c.194A>T (p.Asn65Ile) [Uncertain significance]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 7 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Não-compactação ventricular esquerda

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

3 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

7 ensaios clínicos encontrados, 3 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
586 papers (10 anos)
#1

Familial left ventricular noncompaction cardiomyopathy associated with the p.Asp461Asn MYH7 variant.

Open life sciences2026 Jan

Left ventricular noncompaction cardiomyopathy (LVNC) is a distinct form of cardiomyopathy that may present as either an inherited or a sporadic condition. This report describes the first documented case of familial LVNC associated with the MYH7 p.Asp461Asn variant. Phenotypic variability among affected individuals within the family was assessed to identify potential contributors to the observed clinical heterogeneity in LVNC. The reported family included 10 individuals across three generations. Two members were diagnosed with LVNC, and 1 was classified as having suspected LVNC. Identical twins (Ⅱ-1 and Ⅱ-3) were both found to harbor the heterozygous missense variant c.1381G > A (p.Asp461Asn) in the MYH7 gene. Subsequent pedigree analysis confirmed the presence of this variant in individuals Ⅲ-1, Ⅲ-2, and Ⅲ-4. Clinical observations from this familial case highlight the importance of early identification and intervention in patients with LVNC to mitigate the risks of heart failure, sudden cardiac death, and thromboembolic events. The MYH7 variant plays a significant role in the pathogenesis of LVNC and may represent a promising target for future gene-based therapies aimed at improving patient outcomes.

#2

Digenic sarcomeric variants in paediatric dilated cardiomyopathy and maternal peripartum cardiomyopathy: a familial case report.

European heart journal. Case reports2026 Feb

Left ventricular non-compaction (LVNC) can be observed as a phenotypic trait in patients with dilated cardiomyopathy. Familial cases have been increasingly recognized, with sarcomeric gene mutations-particularly in MYH7 and MYBPC3-playing a significant role. Peripartum cardiomyopathy (PPCM) may also share overlapping genetic architecture with inherited cardiomyopathies. We report a 7-year-old girl with a clinical diagnosis of dilated cardiomyopathy with LVNC since infancy. Genetic analysis revealed two heterozygous missense variants in sarcomeric genes associated with inherited cardiomyopathies: MYH7: c.4186C>T (p.Arg1396Trp) and MYBPC3: c.2672G>A (p.Arg891Gln), both classified as variants of uncertain significance. Segregation analysis showed that the MYH7 variant was maternally inherited and the MYBPC3 variant paternally inherited. Notably, the mother developed PPCM 4 months postpartum, with an ejection fraction (EF) of 35%-40%, and was found to carry the same MYH7 variant. The father remained asymptomatic. This case highlights a potential familial cardiomyopathy syndrome with phenotypic variability: the child presenting with an dilated cardiomyopathy with LVNC phenotype and the mother with PPCM. The presence of distinct cardiomyopathy phenotypes within the same family carrying shared and separate sarcomeric variants suggests a possible genotype-phenotype correlation, emphasizing the importance of comprehensive genetic screening and long-term familial surveillance in such cases. This report highlights the clinical relevance of identifying digenic sarcomeric variants in paediatric cardiomyopathy, particularly when associated with a positive maternal history of PPCM. Familial evaluation and recognition of genotypic overlap may aid in risk stratification and management.

#3

FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes.

Stem cell research & therapy2026 Jan 16

Inherited cardiomyopathy (ICM) is a genetic disorder characterized by abnormal myocardial structure and function, often progressing to heart failure. FHOD3, a member of the Formin gene family, plays a crucial role in cardiomyocyte cytoskeletal organization. Mutations in FHOD3 have been associated with various cardiomyopathies, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and left ventricular noncompaction (LVNC). However, the molecular mechanisms underlying FHOD3 deficiency-induced cardiomyopathy remain elusive. A FHOD3 knockout (FHOD3-/-) human embryonic stem cell (hESC) line was generated using the CRISPR/Cas9 system and subsequently differentiated into cardiomyocytes (hESC-CMs). Sarcomere structure, calcium handling, mitochondrial function, and contractility were evaluated via immunofluorescence, electron microscopy, Seahorse metabolic analysis, and high-definition video analysis, respectively. Transcriptomic sequencing was performed to identify differentially expressed genes and enriched pathways. FHOD3-deficient hESC-CMs exhibited marked sarcomere disorganization and degradation, impaired calcium handling and compromised mitochondrial function, ultimately leading to reduced contractility. Transcriptomic analysis revealed significant downregulation of sarcomere-related genes and calcium-handling genes, with enrichment in pathways associated with cardiomyopathy and calcium signaling. Furthermore, FHOD3 deficiency triggered the phosphorylation of CaMKII (Thr286), a key regulator of cardiac hypertrophy and remodeling, contributing to the progression of heart failure. Treatment with the myosin activator Omecamtiv mecarbil (OM) partially restored contractility without affecting calcium handling, highlighting its potential as a therapeutic strategy. Our study establishes a valuable human-derived model for investigating the molecular mechanisms of FHOD3 deficiency-induced cardiomyopathy. This model allows for extensive investigation into the phenotypes caused by FHOD3 deficiency and identifies CaMKII activation as a crucial factor contributing to the HF phenotype. Additionally, this model serves as an important tool for discovering novel therapeutic agents, and we demonstrate that OM can partially improve myocardial function in FHOD3 KO hESC-CMs. Barth syndrome is a multisystem disorder characterized in affected males by cardiomyopathy, neutropenia, skeletal myopathy, and prepubertal growth delay; however, not all features may be present in an affected male. Cardiomyopathy, which is almost always present before age five years, is typically dilated cardiomyopathy with or without endocardial fibroelastosis or left ventricular noncompaction; hypertrophic cardiomyopathy can also occur. Heart failure is a significant cause of morbidity and mortality; risk of arrhythmia and sudden death is increased. Neutropenia is most often associated with bacterial infections and aphthous ulcers, pneumonia, and sepsis. Skeletal myopathy predominantly affects the proximal muscles, and results in delays in development of early motor skills. Prepubertal growth delay is followed by a postpubertal growth spurt with remarkable "catch-up" growth. Heterozygous females who have a normal karyotype are asymptomatic and have normal biochemical studies. The diagnosis of Barth syndrome is established in a male proband with suggestive findings and either an increased monolysocardiolipin-to-cardiolipin ratio (if available) or a hemizygous pathogenic variant in TAFAZZIN (formerly TAZ) identified by molecular genetic testing. The diagnosis of Barth syndrome is usually established in a female proband with suggestive clinical findings and a heterozygous TAFAZZIN pathogenic variant identified by molecular genetic testing. Targeted therapy: Elamipretide is indicated for the improvement of muscle strength in individuals with Barth syndrome. Treatment of manifestations: Standard treatment of cardiac issues include: (1) for cardiac arrhythmia, consideration of antiarrhythmic medications or implantable cardiac defibrillator (ICD); (2) for heart failure, careful fluid and volume management and avoidance of overdiuresis and dehydration, standard heart failure medications, and cardiac transplantation when heart failure is severe and intractable. Interventions for other findings include granulocyte colony-stimulating factor for neutropenia; physical therapy for skeletal muscle weakness; standard treatment for talipes equinovarus and/or scoliosis; feeding therapy and consideration of gastrostomy tube placement for persistent feeding issues; uncooked cornstarch prior to bedtime for hypoglycemia; standard management of developmental delay / intellectual disability. Prevention of secondary complications: Aspirin therapy to prevent clot formation in those with severe cardiac dysfunction and/or marked left ventricular noncompaction; antibiotic prophylaxis to prevent recurrent infections; limit fasting or provide intravenous glucose infusion prior to planned medical procedures; regularly monitor blood potassium concentrations during administration of IV fluids that contain potassium and during episodes of diarrhea; consult with nutritionist and/or gastroenterologist to determine optimal caloric delivery. Surveillance: Monitoring existing manifestations, the individual's response to supportive care, and the emergence of new manifestations requires at least annual electrocardiography with Holter monitor and echocardiography; as-needed electrophysiologic studies to assess for potentially serious cardiac arrhythmia; at least semiannual complete blood count with differential as well as with all febrile episodes; at each visit, measurement of height and weight, clinical assessment of strength, and clinical assessment for scoliosis; every three to five years during childhood, formal assessments of developmental progress and educational needs. Agents/circumstances to avoid: Prolonged fasting, use of rectal thermometers in those with neutropenia, and use of succinylcholine. Although growth hormone is typically not indicated as most affected males will attain normal stature by adulthood, recommendations about use of human growth hormone may vary based on endocrinology testing and recommendations. The muscular involvement in Barth syndrome may increase the risk for malignant hyperthermia compared to the general population. Evaluations of relatives at risk: Molecular genetic testing (if the TAFAZZIN pathogenic variant in the family is known) or monolysocardiolipin-to-cardiolipin ratio testing (if the TAFAZZIN pathogenic variant in the family is not known) of male sibs of a proband and male relatives in the maternal lineage is appropriate to identify as early as possible those who would benefit from initiation of treatment and preventive measures. Barth syndrome is inherited in an X-linked manner. If the mother of the proband has a TAFAZZIN pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected. Females who inherit the pathogenic variant will be heterozygotes. Heterozygous females typically do not manifest the disease. Affected males transmit the TAFAZZIN pathogenic variant to all of their daughters and none of their sons. If the TAFAZZIN pathogenic variant has been identified in an affected family member, identification of female heterozygotes and prenatal/preimplantation genetic testing for Barth syndrome are possible.

#4

Invasion of Epicardial-Derived Cells to the Trabeculae Mediated by NFPs-Fgf Signaling Regulates Ventricular Compaction.

Circulation. Heart failure2026 Feb

Left ventricular noncompaction cardiomyopathy (LVNC; OMIM No. 604169) is anatomically characterized by excess trabeculation and deep intertrabecular recesses. It is the third most prevalent pediatric cardiomyopathy. Despite its clinical significance, the pathogenesis of LVNC remains uncertain. We examined Numb expression in epicardial cells (EpiCs) and epicardial-derived cells (EPDCs) using a mCherry::Numb knock-in mouse line; used Tbx18Cre/+ and inducible WT1CreERT2/+ to generate epicardium-specific Numb and Numblike double knockouts (epicardial Nb;Nl double knockout [EDKO]) and inducible EpiC-specific Nb;Nl knockout, respectively; monitored EpiCs/EPDCs invasion into the myocardium by lineage tracing; assessed LVNC defects via the ratio of noncompact to compact zone thickness/area; utilized single-nuclei mRNA sequencing and biochemical tools to determine the disrupted molecular mechanisms of EDKOs; and used pharmacological approaches to rescue defects in EDKOs. Cardiac structural and functional changes in adult stages were examined using echocardiography and histochemistry. Sample sizes ranged from 3 to 9 hearts across experiments. Numb is enriched in EpiCs and EPDCs. In EDKO hearts, EPDCs displayed abnormal differentiation, and their migration was arrested at the outer compact zone, resulting in the absence of EPDCs in the inner compact zone and trabeculae. The EDKO hearts displayed LVNC, and inducible EpiC-specific Nb;Nl knockouts (induced at embryonic day 10.5) recapitulated the defects. Single-nuclei mRNA sequencing revealed the upregulation of Fgfr1 (fibroblast growth factor receptor 1) in epicardium and the downregulation of Fgf (fibroblast growth factor) ligands in cardiomyocytes in EDKOs. Exogenous Fgf2 supplementation to pregnant females partially rescued epithelial-mesenchymal transition and compaction defects in EDKO hearts. Female EDKOs survived to adulthood and maintained LVNC. Ablation of NFPs (Numb family proteins) in EpiCs disrupted the invasion and differentiation of EPDCs and the communication between cardiomyocytes and other cells, and caused LVNC. The epithelial-mesenchymal transition and compaction defects can be partially rescued by exogenous Fgf2 supplementation. Our findings highlight an essential role for the epicardial NFPs-Fgf/Fgfr axis in regulating ventricular compaction.

#5

Intermittent High-Grade Atrioventricular Block as a Presenting Sign of Left Ventricular Noncompaction.

JACC. Case reports2026 Mar 25

Left ventricular noncompaction is characterized by excessive trabeculation and is variably associated with heart failure, arrhythmias, thromboembolism, and conduction disease. A 37-year-old man with palpitations and chest discomfort had intermittent high-grade (Mobitz II) atrioventricular block on event monitoring (3.7-second pause). Cardiac magnetic resonance revealed apicolateral hypertrabeculation with a diastolic noncompacted:compacted ratio of 3.5 without late gadolinium enhancement; transthoracic echocardiography showed preserved ejection fraction (60%). Electrophysiology recommended longitudinal rhythm surveillance with an implantable loop recorder; pacemaker was deferred. Genetic testing was advised but not authorized by insurance. Intermittent high-grade atrioventricular block can be an initial manifestation of left ventricular noncompaction with preserved systolic function. Recognition of this association supports advanced imaging in unexplained conduction disease in young adults and favors loop-recorder-guided surveillance with multidisciplinary follow-up, including genetics. Unexplained high-grade atrioventricular block in a young adult should prompt advanced structural evaluation-including cardiac magnetic resonance-to exclude left ventricular noncompaction and other cardiomyopathies. Preserved ejection fraction and absent late gadolinium enhancement can coexist with clinically relevant conduction disease in left ventricular noncompaction. Implantable loop recorder-guided surveillance enables individualized timing of device therapy and complements genetic evaluation and cascade family screening.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC728 artigos no totalmostrando 198

2026

Intermittent High-Grade Atrioventricular Block as a Presenting Sign of Left Ventricular Noncompaction.

JACC. Case reports
2026

Familial left ventricular noncompaction cardiomyopathy associated with the p.Asp461Asn MYH7 variant.

Open life sciences
2026

LMNA-p.Arg78Trp and MYH6-p.Val893Met Mutations Associated with Left Ventricular Noncompaction.

Combinatorial chemistry & high throughput screening
2026

Left Ventricular Non-Compaction Cardiomyopathy: The Tragedies & Trabeculations of the Architectural Cardiac Sponge.

Journal of clinical medicine
2026

Diagnostic utility of cardiac magnetic resonance-derived myocardial strain and fractal analysis in differentiating left ventricular noncompaction from dilated cardiomyopathy.

BMC medical imaging
2026

Diagnostic Dilemma in Left Ventricular Noncompaction Cardiomyopathy: Thrombus or Tumor?

Cureus
2026

An infant case of double-chambered left ventricle with extensive non-compaction revealed by intraoperative endoscopy.

Journal of cardiology cases
2026

The spongy heart paradox: balancing bleeding and clotting risk in left ventricular noncompaction cardiomyopathy.

Heart failure reviews
2026

Digenic sarcomeric variants in paediatric dilated cardiomyopathy and maternal peripartum cardiomyopathy: a familial case report.

European heart journal. Case reports
2026

NONO-Related Syndromic X-Linked Developmental Disability 34: Further Clinical and Molecular Delineation in a Prenatal Cohort.

Prenatal diagnosis
2026

Left Ventricular Noncompaction Syndrome.

Cardiology in review
2026

Clinical phenotypes across age groups and the predictive value of NT-proBNP for ventricular arrhythmias in left ventricular non-compaction: a multicenter cohort study.

Journal of translational medicine
2026

De Novo ACTN2 Variant in a Chinese Neonate With Left Ventricular Non-Compaction and Metabolic Disturbances: A Rare Case Report.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2026

FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes.

Stem cell research & therapy
2025

Predictors of life-threatening events in adult patients with left ventricular noncompaction.

World journal of cardiology
2026

Invasion of Epicardial-Derived Cells to the Trabeculae Mediated by NFPs-Fgf Signaling Regulates Ventricular Compaction.

Circulation. Heart failure
2025

Common Ancestry from Southern Italy: Two Families with Dilated Cardiomyopathy Share the Same Homozygous Loss-of-Function Variant in NRAP.

Genes
2025

A Rare Case of Left Ventricular Noncompaction Discovered During Severe Rhythm Disorder: About a Case Report.

Clinical case reports
2025

Case Report: Hypertrophic cardiomyopathy meets left ventricular hypertrabeculation: from mixed cardiomyopathy to hypertrophic cardiomyopathy with hypertrabeculation.

Frontiers in cardiovascular medicine
2025

Optimizing the Diagnostic Assessment of Left Ventricular Noncompaction Cardiomyopathy: The Clinical Value of Cardiac Magnetic Resonance Imaging.

Current medical imaging
2025

Metabolic remodeling and cardiac dysfunction in left ventricular noncompaction: Insights from the MYH7 Q315R model.

PloS one
2025

Are NONO variants linked to congenital heart disease? Patient reports and review.

European journal of medical genetics
2025

A ryanodine receptor 2 gene variant associated with left ventricular non-compaction, cardiac conduction disease, ventricular arrhythmias, and sudden cardiac death.

Cardiology in the young
2025

Left Ventricular Non-Compaction Cardiomyopathy: A Review of the Pathophysiology, Epidemiology, Diagnosis, Genetics, and Clinical Management.

Journal of personalized medicine
2025

Dual Renal and Cardiac Phenotypes Associated with Rare Variants Inherited from Both Parents.

Internal medicine (Tokyo, Japan)
2025

Multimodality CMR diagnosis of double-chambered left ventricle in a child: A case report.

Medicine
2025

CMR-FT right atrial strain is a novel predictive indicator in left ventricular noncompaction patients: a multi-center study.

Journal of translational medicine
2026

Left ventricular noncompaction cardiomyopathy and mitral annular disjunction in a patient undergoing cardiotoxic therapy for breast cancer.

Kardiologia polska
2025

Left Ventricular Noncompaction Cardiomyopathy in Children: A Focus on Genetic and Molecular Mechanisms.

Reviews in cardiovascular medicine
2025

Surgical Repair Of Severe Mitral And Tricuspid Valve Regurgitation In Patient With Left Ventricle Noncompaction - A Case Report.

Portuguese journal of cardiac thoracic and vascular surgery
2025

Complete Myocardial Bridging.

JACC. Case reports
2026

Cardiac CT fractal analysis of LV noncompaction and common cardiomyopathies.

Journal of cardiovascular computed tomography
2025

Critical predictors of heart transplant necessity in children with advanced DCM.

Italian journal of pediatrics
2025

Immuhistochemically-confirmed mitochondrial cardiomyopathy presenting as a conduction system hamartoma: A case report.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
2025

Double-Chambered Left Ventricle: How Cardiac Magnetic Resonance Overturned the Diagnosis.

JACC. Case reports
2025

Left Ventricular Noncompaction Cardiomyopathy in an Elderly Patient: A Case Report.

Cureus
2025

Deletion of Ptpmt1 by αMHC-Cre in Mice Results in Left Ventricular Non-Compaction.

Journal of developmental biology
2025

Saw-tooth cardiomyopathy from foetal to neonatal period: a case report and literature review.

European heart journal. Case reports
2025

Role of Col1a2 and Postn in left ventricular noncompaction cardiomyopathy.

Journal of cardiothoracic surgery
2025

A rare HCN4 variant combined with sick sinus syndrome, left ventricular noncompaction, and complex congenital heart disease.

Channels (Austin, Tex.)
2025

Dysfunction of PDE4DIP contributes to LVNC development by regulating cell polarity, skeleton, and energy metabolism via Rho-ROCK pathway.

Genes & diseases
2025

Comparison of Imaging Modalities for Left Ventricular Noncompaction Morphology.

Journal of imaging
2025

Isolated Right Atrial Enhancement with Atrial Standstill: An Uncommon Presentation of Emery-Dreifuss Muscular Dystrophy.

The Indian journal of radiology & imaging
2025

A ViTUNeT-based model using YOLOv8 for efficient LVNC diagnosis and automatic cleaning of dataset.

Journal of integrative bioinformatics
2025

ACTC1 Variants Result in Isolated and Syndromic Cardiac Phenotypes.

Clinical genetics
2025

Left Ventricular Noncompaction Cardiomyopathy.

JAMA cardiology
2025

Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy.

PloS one
2025

Barth Syndrome: TAFAZZIN Gene, Cardiologic Aspects, and Mitochondrial Studies-A Comprehensive Narrative Review.

Genes
2025

Prognostic Value of Compact Myocardial Thinning in Patients With Left Ventricular Noncompaction.

The American journal of cardiology
2025

Noncompaction and dilated cardiomyopathy in carvajal syndrome.

Cardiology in the young
2025

Anesthetic Challenges of Labor and Delivery in a Patient With Catecholaminergic Polymorphic Ventricular Tachycardia and Left Ventricular Non-Compaction Cardiomyopathy.

Clinical case reports
2025

Advanced Imaging in the Diagnosis of Cardiac Sarcoid and LV Noncompaction.

JACC. Case reports
2025

Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies.

Current cardiology reports
2025

Reduced myocardial CARF and the underlying implications in left ventricular noncompaction cardiomyopathy.

International journal of cardiology
2025

Loss of conserved long non-coding RNA MIR503HG leads to altered NOTCH pathway signalling and left ventricular non-compaction cardiomyopathy.

Cardiovascular research
2025

Left Ventricular Noncompaction in Advanced Heart Failure With an Anomalous Coronary Artery: A Case Report.

Cureus
2025

Abnormal P wave terminal force in lead V1 is correlated with adverse cardiac remodeling in patients with left ventricular noncompaction: A useful noninvasive indicator of disease severity.

Journal of electrocardiology
2025

Beyond convention: non-compacted myocardium, ventricular tachycardia, and systolic dysfunction in dextrocardia patients: a case series.

Annals of medicine and surgery (2012)
2025

Lack of Bridge to Recovery in Pediatric Dilated Cardiomyopathy With Left Ventricular Noncompaction.

Annals of thoracic surgery short reports
2025

Pulmonary artery banding for dilated and depressed left ventricle: dilated cardiomyopathy versus left ventricular non-compaction cardiomyopathy.

Cardiology in the young
2025

The Role of the MTUS1 Gene in the Development of Left Ventricular Noncompaction Cardiomyopathy-A Case Report.

Genes
2025

Throwing thrombi: noncompaction cardiomyopathy causing renal infarct and catastrophic stroke - a case report.

BMC cardiovascular disorders
2025

How to Approach Left Ventricular Hypertrabeculation: A Practical Guide and Literature Review.

Journal of clinical medicine
2025

A rare genetic variant in PRDM16 is associated with Wolff-Parkinson-White syndrome with complex accessory pathway characteristics and left ventricular non-compaction cardiomyopathy.

Cardiology in the young
2025

Cardiac resynchronization therapy via left bundle branch pacing in heart failure with complete left bundle branch block: is the defibrillator needed?

Frontiers in cardiovascular medicine
2025

Left Ventricular Non-Compaction, Atrial Fibrillation and ANK2 Mutation in a Young Athlete.

Journal of clinical medicine research
2025

Incidence and Impact of Myocarditis in Genetic Cardiomyopathies: Inflammation as a Potential Therapeutic Target.

Genes
2024

Successful heart transplantation after 4 years of bridging with HeartWare HVAD for left ventricular noncompaction in an 11-year-old boy with prohibitively high pulmonary vascular resistance.

Annals of pediatric cardiology
2025

Semi-Automatic Refinement of Myocardial Segmentations for Better LVNC Detection.

Journal of clinical medicine
2025

NONO-related X-linked intellectual disability syndrome: Further clinical and molecular delineation.

European journal of medical genetics
2024

Fetal bradycardia associated with left ventricle noncompaction diagnosed as HCN4 mutations.

Annals of pediatric cardiology
2024

BAG-3 Mutation Dilated Cardiomyopathy With Left Ventricular Noncompaction in Young Healthy Adult.

JACC. Case reports
2024

Novel Mutation Lys30Glu in the TPM1 Gene Leads to Pediatric Left Ventricular Non-Compaction and Dilated Cardiomyopathy via Impairment of Structural and Functional Properties of Cardiac Tropomyosin.

International journal of molecular sciences
2024

The Role of Echocardiography in the Diagnosis of Left Ventricular Noncompaction: Usefulness in a Resource-Constrained Setting.

Clinical case reports
2025

Clinical observation of 4 cases of cerebral infarction caused by left ventricular noncompaction.

The American journal of emergency medicine
2024

A tri-leaflet mitral valve with left ventricular non-compaction cardiomyopathy.

European heart journal. Imaging methods and practice
2024

Dilated Cardiomyopathy: A Genetic Journey from Past to Future.

International journal of molecular sciences
2024

Determination of Genotype and Phenotypes in Pediatric Patients With Biventricular Noncompaction.

Journal of the American Heart Association
2024

Morphological, electrophysiological, and molecular alterations in foetal noncompacted cardiomyopathy induced by disruption of ROCK signalling.

Frontiers in cell and developmental biology
2024

Searching for genetic determinants for left ventricular non-compaction.

Quantitative imaging in medicine and surgery
2024

Prevalence, Clinical Manifestations, and Adverse Outcomes of Left Ventricular Noncompaction in Adults: A Systematic Review and Meta-Analysis.

Cardiology research
2024

Left Ventricular Non-Compaction: Evolving Concepts.

Journal of clinical medicine
2024

Cardiomyopathy-Associated Chronic Heart Failure in Infants Aged <1 Year: A Prospective Observational Cohort Over 5 Years in Northern China.

Journal of the American Heart Association
2025

Genophenotypic correlates and long-term outcome prognosticators of left ventricular non-compaction in children.

Journal of the Formosan Medical Association = Taiwan yi zhi
2024

Congenital Left Ventricular Aneurysm.

JACC. Case reports
2024

The effect of excessive trabeculation on cardiac rotation-A multimodal imaging study.

PloS one
2024

Left Ventricular Non-compaction Cardiomyopathy: A Report of a Rare Case From Saudi Arabia.

Cureus
2024

What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question.

Current problems in cardiology
2024

Titin Cardiomyopathy Associated With Refractory Ventricular Tachycardia: A Case Report.

Cureus
2024

Pathophysiological and Pedigree Analysis of Left Ventricular Noncompaction in Japanese Macaques (Macaca fuscata).

Comparative medicine
2024

A Rare Coincidence of Three Inherited Diseases in a Family with Cardiomyopathy and Multiple Extracardiac Abnormalities.

International journal of molecular sciences
2024

Hypereosinophilia and Left Ventricular Thrombus: A Case Report and Literature Review.

Cureus
2024

Isolated left ventricular non-compaction: Clinical characterisation of a teenage male.

JPMA. The Journal of the Pakistan Medical Association
2024

Watchful Waiting: Echocardiographic Surveillance of Childhood Left Ventricular Noncompaction.

JACC. Advances
2024

Left Ventricular Noncompaction in Childhood: Echocardiographic Follow-Up and Prevalence in First-Degree Relatives.

JACC. Advances
2024

Exploring the Unknown: Appreciating the Challenges of Non-compaction Cardiomyopathy.

Cureus
2024

A neonate with a spongy failing heart - What could it be?

Annals of pediatric cardiology
2024

Molecular Pathways and Animal Models of Ebstein's Anomaly.

Advances in experimental medicine and biology
2024

Cardiac Transcription Factors and Regulatory Networks.

Advances in experimental medicine and biology
2024

Left Ventricle Noncompaction Phenotype: Cause or Consequence?

Journal of cardiovascular echography
2024

Severe Regurgitant Bicuspid Aortic Valve in a Patient with Overlapping Left Ventricular Noncompaction and Asymmetrical Septal Hypertrophy.

Journal of cardiovascular echography
2024

Left Ventricular Non-compaction and Associated Cardiomyopathy Presenting With Cardiac Failure: A Case Report.

Cureus
2024

Myosin Heavy Chain 7 (MYH7) Variant Associated Cardiovascular Disease: An Unusual Case of Heart Failure in a Young Male.

Cureus
2024

Bilateral Renal Infarct in a Young Adult: Unveiling an Autoimmune Enigma.

Cureus
2023

Case Report: Challenges in the etiology of left ventricular aneurysm.

F1000Research
2024

Electrophysiological phenotyping of left ventricular noncompaction cardiomyopathy in pediatric populations: A systematic review.

Physiological reports
2024

A review regarding the article 'Advances and Challenges in the Diagnosis and Management of Left Ventricular Noncompaction in Adults.'.

Current problems in cardiology
2024

Advances and challenges in the diagnosis and management of left ventricular noncompaction in adults: A literature review.

Current problems in cardiology
2024

Left ventricular function assessment including or excluding trabeculations in left ventricular non-compaction, a preliminary case-control cardiac magnetic resonance study.

Quantitative imaging in medicine and surgery
2024

Novel MYH7 Variant in the Neonate of a Mother with Gestational Diabetes Mellitus Showing Left Ventricular Hypertrophy and Noncompaction.

Genes
2024

Transcription Factors Leave Their Mark on the Heart.

Circulation. Genomic and precision medicine
2024

Sudden unexpected intrapartum death and left ventricular noncompaction involving the right ventricle.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
2024

A rare case of mitral valve dysplasia and left ventricular noncompaction: surgical management and genetic investigation.

Quantitative imaging in medicine and surgery
2024

Impact of Cardiac Magnetic Resonance on the Diagnosis of Left Ventricular Noncompaction-A 15-Year Experience.

Journal of clinical medicine
2024

Genetic, clinical and imaging implications of a noncompaction phenotype population with preserved ejection fraction.

Frontiers in cardiovascular medicine
2024

Pregnancy and cardiac maternal outcomes in women with inherited cardiomyopathy: interest of the CARPREG II risk score.

ESC heart failure
2024

Long-term prognostic value of thyroid hormones in left ventricular noncompaction.

Journal of endocrinological investigation
2024

Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction.

Circulation. Genomic and precision medicine
2024

Cellular-level analyses of SCN5A mutations in left ventricular noncompaction cardiomyopathy suggest electrophysiological mechanisms for ventricular tachycardia.

Biochemistry and biophysics reports
2024

Ebstein's Anomaly of the Tricuspid Valve, Mitral Valve Prolapse and Left Ventricular Non-Compaction: A Triple Trouble.

Heart, lung &amp; circulation
2026

Titin: The Missing Link in Cardiac Physiology.

Cardiology in review
2023

LEFT VENTRICULAR NONCOMPACTION CARDIOMYOPATHY: A SCOPING REVIEW.

Annals of Ibadan postgraduate medicine
2023

Myocardial Mechanics and Associated Valvular and Vascular Abnormalities in Left Ventricular Noncompaction Cardiomyopathy.

Journal of clinical medicine
2024

RETRACTED: Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria.

Diagnostics (Basel, Switzerland)
2023

Left Ventricular Noncompaction Cardiomyopathy Diagnosis in a Patient Presenting with Epileptic Seizure: A "Double-edged Sword".

Innovations in clinical neuroscience
2023

Catheter Ablation of Left Ventricular Summit Ectopies in Left Ventricular Noncompaction.

Journal of medical cases
2024

The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study.

European journal of pediatrics
2024

Novel compound heterozygous variants in EMC1: Overlapping phenotypes of left ventricular noncompaction and long QT syndrome warranting in-depth exploration.

Prenatal diagnosis
2024

Impella 5.5 in left ventricular noncompaction syndrome as bridge to heart transplant.

JHLT open
2023

Improving a Deep Learning Model to Accurately Diagnose LVNC.

Journal of clinical medicine
2023

Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.

Circulation. Heart failure
2024

A novel NONO nonsense variant in a fetus with renal abnormalities.

Prenatal diagnosis
2024

Multidisciplinary approach in cardiomyopathies: From genetics to advanced imaging.

Heart failure reviews
2023

Highlights of right ventricular characteristics of left ventricular noncompaction using 3D echocardiography.

International journal of cardiology. Heart &amp; vasculature
2024

Clinical and genetic characteristics of catecholaminergic polymorphic ventricular tachycardia combined with left ventricular non-compaction.

Cardiology in the young
2023

[Clinical phenotype and genetic analysis of patients with left ventricular noncompaction caused by the biallelic mutation of MYBPC3 and MYH7].

Zhonghua xin xue guan bing za zhi
2023

Early Onset Parkinson Syndrome, Type A Aortic Aneurysm and Noncompaction Associated With the Novel Variant c.2225C>T in MYH11: A Case Report.

Cureus
2023

Left Ventricular Noncompaction Cardiomyopathy and Myocardial Bridging Association: A Coincidence Or a Usual Association?

Journal of the Saudi Heart Association
2023

Unmasking the uncommon: bidirectional ventricular tachycardia in two rare paediatric cardiomyopathies.

Cardiology in the young
2023

A Rare Case of an Infant With 1p36 Deletion Syndrome Presenting With Systolic Heart Failure Secondary to Severe Dilated Cardiomyopathy.

Cureus
2024

Left ventricular entropy: A promising predictor of cardiovascular events in patients with left ventricular noncompaction.

International journal of cardiology
2023

Pronounced QT Prolongation During General Anesthesia in a Child with Left Ventricular Noncompaction Cardiomyopathy: A Case Report.

Anesthesia progress
2023

Left Ventricular Noncompaction in Concomitance With Heroin Use Disorder.

Cureus
2023

Pregnancy Outcomes in Left Ventricular Noncompaction.

The American journal of cardiology
2023

Case report: A rare case of left ventricular noncompaction in two Chinese siblings with becker muscular dystrophy caused by deletion of exons 10 to 12 in the DMD gene.

Frontiers in cardiovascular medicine
2023

Long-Term Prognosis of Different Subtypes of Left Ventricular Noncompaction Cardiomyopathy Patients: A Retrospective Study in China.

Journal of cardiovascular development and disease
2023

Marfan Syndrome, Giant Ascending Aortic Aneurysm, and Left Ventricular Noncompaction: The Heart in Jeopardy!

Cureus
2023

Characteristics of the right ventricle in left ventricular noncompaction with reduced ejection fraction in the light of dilated cardiomyopathy.

PloS one
2023

Accurate Classification of Non-ischemic Cardiomyopathy.

Current cardiology reports
2023

Left ventricular noncompaction cardiomyopathy and short QT syndrome due to primary carnitine deficiency.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc
2023

Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.

International journal of cardiology
2023

Establishment and identification of cardiomyocyte arhGEF18 gene conditional knockout mice.

Pediatric discovery
2023

Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C.

International journal of molecular sciences
2023

Left ventricular noncompaction in Ibadan, Nigeria.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology
2023

Case Report: Non-ossifying fibromas with pathologic fractures in a patient with NONO-associated X-linked syndromic intellectual developmental disorder.

Frontiers in genetics
2023

New Scenarios in Heart Transplantation and Persistency of SARS-CoV-2 (Case Report).

Life (Basel, Switzerland)
2023

Prinzmetal angina in a child with actin gene ACTC1 mutation.

Cardiology in the young
2023

A novel mutation in the TTN gene resulted in left ventricular noncompaction: a case report and literature review.

BMC cardiovascular disorders
2023

Variants in ACTC1 underlie distal arthrogryposis accompanied by congenital heart defects.

HGG advances
2024

The impact of fragmented QRS on clinical findings and outcomes in children with dilated cardiomyopathy with or without left ventricular non-compaction.

Cardiology in the young
2023

The Rare Condition of Left Ventricular Non-Compaction and Reverse Remodeling.

Life (Basel, Switzerland)
2023

Non-Compaction Ventricle and Associated Cardiovascular and Non-Cardiovascular Diseases; More Attention Is Needed!

Life (Basel, Switzerland)
2023

Low-frequency maternal novel MYH7 mosaicism mutation in recurrent fetal-onset severe left ventricular noncompaction: a case report.

Frontiers in pediatrics
2023

Genetic landscape in Russian patients with familial left ventricular noncompaction.

Frontiers in cardiovascular medicine
2023

Increased Ca2+ Transient Underlies RyR2-Related Left Ventricular Noncompaction.

Circulation research
2023

Anomalous origin of the left circumflex artery from the pulmonary artery associated with non-compaction of the left ventricle: usefulness of multimodality imaging-a case report.

European heart journal. Case reports
2023

Multimodality Imaging and Biomarker Approach to Characterize the Pathophysiology of Heart Failure in Left Ventricular Non-Compaction with Preserved Ejection Fraction.

Journal of clinical medicine
2023

Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement From the American Heart Association.

Circulation
2023

Left Ventricular Noncompaction Cardiomyopathy in an Elderly Patient: A Case Report and Literature Review.

Cureus
2023

Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1.

Circulation research
2023

The Value of Multimodal Imaging in Early Phenotyping of Cardiomyopathies: A Family Case Report.

Journal of personalized medicine
2023

Advances in symptomatic therapy for left ventricular non-compaction in children.

Frontiers in pediatrics
2023

Altered contractility, Ca2+ transients, and cell morphology seen in a patient-specific iPSC-CM model of Ebstein's anomaly with left ventricular noncompaction.

American journal of physiology. Heart and circulatory physiology
2023

A case of infantile Barth syndrome with severe heart failure: Importance of splicing variants in the TAZ gene.

Molecular genetics &amp; genomic medicine
2023

Impact of left ventricular noncompaction on brain.

Neurologia i neurochirurgia polska
2023

A rare case of uni-leaflet mitral valve accompanied with left ventricular noncompaction and patent ductus arteriosus.

Echocardiography (Mount Kisco, N.Y.)
2023

Clinical characteristics and management of coexistent cardiomyopathy in patients with bicuspid aortic valve.

Journal of geriatric cardiology : JGC
2023

Whole-exome sequencing revealed a novel Troponin T2 in a pediatric patient with severe isolated left ventricular noncompaction cardiomyopathy.

QJM : monthly journal of the Association of Physicians
2023

Endothelial deletion of PTBP1 disrupts ventricular chamber development.

Nature communications
2023

Can left ventricular entropy by cardiac magnetic resonance late gadolinium enhancement be a prognostic predictor in patients with left ventricular non-compaction?

Diagnostic and interventional radiology (Ankara, Turkey)
2023

New-Onset Heart Failure and Ischemic Stroke in Non-compaction Cardiomyopathy: A Case Report.

Cureus
2023

Evolution in the management of aorta to left ventricular tunnel in a national congenital cardiology centre.

Cardiology in the young
2023

Different methods, different results? Threshold-based versus conventional contouring techniques in clinical practice.

International journal of cardiology
2023

Value of cardiac magnetic resonance feature tracking technology in the differential diagnosis of isolated left ventricular noncompaction and dilated cardiomyopathy.

Quantitative imaging in medicine and surgery
2023

Cardiomyopathies in children: An overview.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
2023

A Novel Case of Acquired Isolated Left Ventricular Non-compaction in a Primigravida: Revisiting the Diagnostic Criteria of Left Ventricular Non-compaction.

Cureus
2023

A novel loss-of-function mutation in NRAP is associated with left ventricular non-compaction cardiomyopathy.

Frontiers in cardiovascular medicine
2023

Prognosis and subtype analysis of left ventricular noncompaction in adults: A retrospective multicenter study.

Clinical cardiology
2023

Excessive Trabeculation of the Left Ventricle: JACC: Cardiovascular Imaging Expert Panel Paper.

JACC. Cardiovascular imaging
2023

Left Ventricular Noncompaction and Coronary Artery Disease: An Unexpected Combination.

Texas Heart Institute journal
2023

Chronic left ventricular apical thrombosis complicating isolated left ventricular noncompaction in a patient with human immunodeficiency virus infection.

Journal of medical ultrasonics (2001)
2023

A Missense Variation in PHACTR2 Associates with Impaired Actin Dynamics, Dilated Cardiomyopathy, and Left Ventricular Non-Compaction in Humans.

International journal of molecular sciences
2022

Cardiac resynchronization therapy in a patient with Ebstein's anomaly and left ventricular noncompaction: Rethink the resync?

HeartRhythm case reports
2022

Three-dimensional Whole-Heart Cardiac MRI Sequence for Measuring Trabeculation in Left Ventricular Noncompaction.

Radiology. Cardiothoracic imaging
2022

Left Atrial Diameter and the Risk of Thromboembolism in Patients with Left Ventricular Noncompaction.

Journal of cardiovascular development and disease
2023

Left ventricular non-compaction cardiomyopathy and ischaemic stroke.

Neurologia i neurochirurgia polska
2022

Electrocardiographic Parameters Associated with Adverse Outcomes in Children with Cardiomyopathies.

Journal of clinical medicine
2022

Prognostic value of cardiac magnetic resonance imaging parameters in left ventricular noncompaction with left ventricular dysfunction.

BMC cardiovascular disorders
Ver todos os 728 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Não-compactação ventricular esquerda.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Não-compactação ventricular esquerda

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Familial left ventricular noncompaction cardiomyopathy associated with the p.Asp461Asn MYH7 variant.
    Open life sciences· 2026· PMID 41878144mais citado
  2. Digenic sarcomeric variants in paediatric dilated cardiomyopathy and maternal peripartum cardiomyopathy: a familial case report.
    European heart journal. Case reports· 2026· PMID 41728227mais citado
  3. FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes.
    Stem cell research &amp; therapy· 2026· PMID 41540467mais citado
  4. Invasion of Epicardial-Derived Cells to the Trabeculae Mediated by NFPs-Fgf Signaling Regulates Ventricular Compaction.
    Circulation. Heart failure· 2026· PMID 41477684mais citado
  5. Intermittent High-Grade Atrioventricular Block as a Presenting Sign of Left Ventricular Noncompaction.
    JACC. Case reports· 2026· PMID 41879597mais citado
  6. A Rare Presentation of Left Ventricular Noncompaction Cardiomyopathy Revealed by Acute Decompensated Heart Failure.
    J Med Cases· 2026· PMID 41953868recente
  7. Hypercortisolism with coronary nonobstructive myocardial infarction and left ventricular noncompaction: a case report.
    Front Cardiovasc Med· 2026· PMID 41929471recente
  8. LMNA-p.Arg78Trp and MYH6-p.Val893Met Mutations Associated with Left Ventricular Noncompaction.
    Comb Chem High Throughput Screen· 2026· PMID 41830141recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:54260(Orphanet)
  2. MONDO:0018901(MONDO)
  3. GARD:10985(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q1725245(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Não-compactação ventricular esquerda
Compêndio · Raras BR

Não-compactação ventricular esquerda

ORPHA:54260 · MONDO:0018901
CID-10
I42.8 · Outras cardiomiopatias
CID-11
Ensaios
3 ativos
Início
All ages
MedGen
UMLS
C1858725
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades